CN109091631A - The Radix Angelicae Sinensis Astragalus in Treating reagent and preparation method for treating early diabetic nephropathy - Google Patents
The Radix Angelicae Sinensis Astragalus in Treating reagent and preparation method for treating early diabetic nephropathy Download PDFInfo
- Publication number
- CN109091631A CN109091631A CN201811035022.6A CN201811035022A CN109091631A CN 109091631 A CN109091631 A CN 109091631A CN 201811035022 A CN201811035022 A CN 201811035022A CN 109091631 A CN109091631 A CN 109091631A
- Authority
- CN
- China
- Prior art keywords
- parts
- astragalus
- angelica
- diabetic nephropathy
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000006533 astragalus Nutrition 0.000 title claims abstract description 20
- 208000007342 Diabetic Nephropathies Diseases 0.000 title claims abstract description 19
- 208000033679 diabetic kidney disease Diseases 0.000 title claims abstract description 19
- 241001061264 Astragalus Species 0.000 title claims abstract description 18
- 210000004233 talus Anatomy 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 11
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 14
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 11
- 235000003805 Musa ABB Group Nutrition 0.000 claims abstract description 11
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 11
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 11
- 235000015266 Plantago major Nutrition 0.000 claims abstract description 11
- 240000008042 Zea mays Species 0.000 claims abstract description 11
- 235000008434 ginseng Nutrition 0.000 claims abstract description 11
- 240000008790 Musa x paradisiaca Species 0.000 claims abstract description 8
- 244000197580 Poria cocos Species 0.000 claims abstract description 7
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 7
- 241000007126 Codonopsis pilosula Species 0.000 claims abstract description 3
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract 2
- 238000004804 winding Methods 0.000 claims description 21
- 238000010298 pulverizing process Methods 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 12
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 10
- 241000304195 Salvia miltiorrhiza Species 0.000 claims description 9
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 9
- 230000004907 flux Effects 0.000 claims description 9
- 230000005855 radiation Effects 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 241000382455 Angelica sinensis Species 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 6
- 238000013178 mathematical model Methods 0.000 claims description 6
- 241000132012 Atractylodes Species 0.000 claims description 5
- 229940124597 therapeutic agent Drugs 0.000 claims description 5
- 241000045403 Astragalus propinquus Species 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 230000005865 ionizing radiation Effects 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 230000003068 static effect Effects 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 230000001360 synchronised effect Effects 0.000 claims description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 241000125175 Angelica Species 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 241000906579 Actaea cimicifuga Species 0.000 claims 1
- 241000112528 Ligusticum striatum Species 0.000 claims 1
- 240000007594 Oryza sativa Species 0.000 claims 1
- 235000007164 Oryza sativa Nutrition 0.000 claims 1
- 241000405414 Rehmannia Species 0.000 claims 1
- 238000007605 air drying Methods 0.000 claims 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims 1
- 235000011477 liquorice Nutrition 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 235000009566 rice Nutrition 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 22
- 210000004369 blood Anatomy 0.000 abstract description 22
- 210000003734 kidney Anatomy 0.000 abstract description 12
- 241000675108 Citrus tangerina Species 0.000 abstract description 11
- 240000000031 Achyranthes bidentata Species 0.000 abstract description 9
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract description 9
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract description 9
- 240000008467 Oryza sativa Japonica Group Species 0.000 abstract description 9
- 235000007244 Zea mays Nutrition 0.000 abstract description 9
- 229940089639 cornsilk Drugs 0.000 abstract description 9
- 229940010454 licorice Drugs 0.000 abstract description 9
- 239000001231 zea mays silk Substances 0.000 abstract description 9
- 241000092665 Atractylodes macrocephala Species 0.000 abstract description 8
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 abstract description 8
- 241000206501 Actaea <angiosperm> Species 0.000 abstract description 7
- 244000061520 Angelica archangelica Species 0.000 abstract description 7
- 241000202726 Bupleurum Species 0.000 abstract description 7
- 244000248557 Ophiopogon japonicus Species 0.000 abstract description 7
- 241000405911 Rehmannia glutinosa Species 0.000 abstract description 7
- 201000001474 proteinuria Diseases 0.000 abstract description 6
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 abstract description 5
- 244000046146 Pueraria lobata Species 0.000 abstract description 5
- 235000010575 Pueraria lobata Nutrition 0.000 abstract description 5
- 230000001225 therapeutic effect Effects 0.000 abstract description 5
- 208000009304 Acute Kidney Injury Diseases 0.000 abstract description 4
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 abstract description 4
- 229930182566 Gentamicin Natural products 0.000 abstract description 4
- 208000033626 Renal failure acute Diseases 0.000 abstract description 4
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 abstract description 4
- 201000011040 acute kidney failure Diseases 0.000 abstract description 4
- 208000012998 acute renal failure Diseases 0.000 abstract description 4
- 229940109239 creatinine Drugs 0.000 abstract description 4
- 229960002518 gentamicin Drugs 0.000 abstract description 4
- 210000000885 nephron Anatomy 0.000 abstract description 4
- 210000005036 nerve Anatomy 0.000 abstract description 4
- 230000008327 renal blood flow Effects 0.000 abstract description 4
- 230000003589 nefrotoxic effect Effects 0.000 abstract description 3
- 231100000381 nephrotoxic Toxicity 0.000 abstract description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 17
- 238000011282 treatment Methods 0.000 description 11
- 240000004371 Panax ginseng Species 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 241000605447 Anemarrhena Species 0.000 description 8
- 241000756943 Codonopsis Species 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 229930191283 anemarrhena Natural products 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 241000205571 Caulophyllum Species 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 240000002045 Guettarda speciosa Species 0.000 description 6
- 241001046532 Sporobolus carolii Species 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 208000001647 Renal Insufficiency Diseases 0.000 description 5
- 201000006370 kidney failure Diseases 0.000 description 5
- 206010000060 Abdominal distension Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 241000234295 Musa Species 0.000 description 4
- 239000002220 antihypertensive agent Substances 0.000 description 4
- 229940127088 antihypertensive drug Drugs 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 3
- 208000037093 Menstruation Disturbances Diseases 0.000 description 3
- 206010027339 Menstruation irregular Diseases 0.000 description 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 241000219780 Pueraria Species 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 208000020832 chronic kidney disease Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 208000028208 end stage renal disease Diseases 0.000 description 3
- 201000000523 end stage renal failure Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 206010018364 Glomerulonephritis Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010065360 Anal prolapse Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000244365 Ligusticum sinense Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 206010058116 Nephrogenic anaemia Diseases 0.000 description 1
- 206010029155 Nephropathy toxic Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 230000007694 nephrotoxicity Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000026843 stiff neck Diseases 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于中药制备技术领域,公开了治疗早期糖尿病肾病的当归黄芪治疗试剂及制备方法;由当归10~15份、黄芪8~11份、茯苓5~8份、人参3~5份、党参3~6份、白术7~10份、玉米须2~4份、陈皮6~10份、升麻10~12份、柴胡10~13份、甘草8~10份、粳米15~20份、知母12~15份、麦冬4~8份、葛根11~15份、熟地10~15份、怀牛膝9~13份、车前草10~15份和川芎6~10份组成。本发明能够补血活血,除烦安神,保护肾脏,减少肾单位的损伤,增加肾血流量,改善肌酐清除率,降低月尿素氮,对急性肾功能衰竭,保护肾脏;能降血糖,减少蛋白尿;并减轻庆大霉素所致的肾毒性损害。
The invention belongs to the technical field of traditional Chinese medicine preparation, and discloses an angelica and astragalus therapeutic reagent for treating early diabetic nephropathy and a preparation method; 10-15 parts of angelica, 8-11 parts of astragalus, 5-8 parts of poria cocos, 3-5 parts of ginseng and 3 parts of codonopsis pilosula ~6 parts, 7~10 parts of Atractylodes macrocephala, 2~4 parts of corn silk, 6~10 parts of tangerine peel, 10~12 parts of Cimicifuga, 10~13 parts of Bupleurum, 8~10 parts of licorice, 15~20 parts of japonica rice, 12-15 parts of female, 4-8 parts of Ophiopogon japonicus, 11-15 parts of kudzu root, 10-15 parts of rehmannia glutinosa, 9-13 parts of Achyranthes bidentata, 10-15 parts of plantain and 6-10 parts of Chuanxiong. The present invention can replenish blood and activate blood, eliminate troubles and soothe the nerves, protect the kidney, reduce nephron damage, increase renal blood flow, improve creatinine clearance rate, reduce monthly urea nitrogen, and protect the kidney against acute renal failure; it can lower blood sugar and reduce proteinuria ; And reduce the nephrotoxic damage caused by gentamicin.
Description
技术领域technical field
本发明属于中药制备技术领域,尤其涉及治疗早期糖尿病肾病的当归黄芪治疗试剂及制备方法。The invention belongs to the technical field of preparation of traditional Chinese medicines, and in particular relates to an angelica astragali therapeutic reagent for treating early diabetic nephropathy and a preparation method thereof.
背景技术Background technique
目前,业内常用的现有技术是这样的:糖尿病肾病是糖尿病病人最重要的合并症之一;糖尿病患者如果发生糖尿病肾病的早期会出现蛋白尿、浮肿、高血压、肾功能不全、贫血等症状;我国的糖尿病肾病发病率亦呈上升趋势,目前已成为终末期肾脏病的第二位原因,仅次于各种肾小球肾炎;由于其存在复杂的代谢紊乱,一旦发展到终末期肾脏病,往往比其他肾脏疾病的治疗更加棘手,因此及时防治对于延缓糖尿病肾病的意义重大;现有的降血压治疗,降压药不能随意停的,停药后甚至会出现升高更严重的现象,长期服用降压药会有全身无力、肌肉张力低下、腹胀、食欲不振、消化不良、心悸等副作用;新型的抗氧化治疗方法需要全身各个方面配合治疗,医药费用高;现有的治疗方法如注射胰岛素,控制饮食虽然能控制病情的发展但是不能有效的调理病情,调理身体,长期还是有病情发展的隐患。At present, the existing technology commonly used in the industry is as follows: diabetic nephropathy is one of the most important complications of diabetic patients; if diabetic patients develop diabetic nephropathy in the early stage, symptoms such as proteinuria, edema, high blood pressure, renal insufficiency, and anemia will appear The incidence of diabetic nephropathy in China is also on the rise, and it has become the second cause of end-stage renal disease, second only to various glomerulonephritis; due to its complex metabolic disorders, once it develops into end-stage renal disease , is often more difficult to treat than other kidney diseases, so timely prevention and treatment is of great significance for delaying diabetic nephropathy; the existing antihypertensive treatment, antihypertensive drugs can not be stopped at will, and even more serious phenomenon will appear after stopping the drug, Long-term use of antihypertensive drugs will cause side effects such as general weakness, low muscle tone, abdominal distension, loss of appetite, indigestion, and palpitations; new anti-oxidation treatments require cooperation from all aspects of the body, and the medical expenses are high; existing treatments such as injections Insulin, although diet control can control the development of the disease, it cannot effectively regulate the disease and the body, and there are still hidden dangers of disease development in the long run.
综上所述,现有技术存在的问题是:In summary, the problems in the prior art are:
(1)我国的糖尿病发病率亦呈上升趋势,目前已成为终末期肾脏病的第二位原因,仅次于各种肾小球肾炎;由于其存在复杂的代谢紊乱,一旦发展到终末期会肾衰竭,往往比其他肾脏疾病的治疗更加棘手,因此及时防治对于延缓糖尿病肾病的意义重大。(1) The incidence of diabetes in my country is also on the rise, and it has become the second cause of end-stage renal disease, second only to various glomerulonephritis; due to its complex metabolic disorders, once it develops to the end stage, it will Kidney failure is often more difficult to treat than other kidney diseases, so timely prevention and treatment is of great significance for delaying diabetic nephropathy.
(2)现有的降血压治疗,降压药不能随意停的,停药后甚至会出现升高更严重的现象,长期服用降压药会有全身无力、肌肉张力低下、腹胀、食欲不振、消化不良、心悸等副作用。(2) In the existing antihypertensive treatment, antihypertensive drugs cannot be stopped at will, and even more serious symptoms may occur after drug withdrawal. Long-term use of antihypertensive drugs will cause general weakness, low muscle tone, abdominal distension, loss of appetite, Indigestion, heart palpitations and other side effects.
(3)新型的抗氧化治疗方法需要全身各个方面配合治疗,医药费用高。(3) The new anti-oxidation treatment method requires the cooperation of all aspects of the whole body, and the medical expenses are high.
(4)现有的治疗方法如注射胰岛素,控制饮食虽然能控制病情的发展但是不能有效的调理病情,调理身体,长期还是有病情发展的隐患。(4) Existing treatment methods such as insulin injection and diet control can control the development of the disease, but they cannot effectively regulate the disease and the body, and there are still hidden dangers of disease development in the long run.
发明内容Contents of the invention
针对现有技术存在的问题,本发明提供了一种治疗早期糖尿病肾病的当归黄芪治疗试剂。Aiming at the problems existing in the prior art, the invention provides an angelica astragalus therapeutic agent for treating early diabetic nephropathy.
本发明是这样实现的,治疗早期糖尿病肾病的当归黄芪治疗试剂按照质量份数由当归10~15份、黄芪8~11份、茯苓5~8份、人参3~5份、党参3~6份、白术7~10份、玉米须2~4份、陈皮6~10份、升麻10~12份、柴胡10~13份、甘草8~10份、粳米15~20份、知母12~15份、麦冬4~8份、葛根11~15份、熟地10~15份、怀牛膝9~13份、车前草10~15份、川芎6~10份、丹参8~10份和神仙草7~10份组成。The present invention is achieved in this way, the Angelica Astragali therapeutic reagent for treating early diabetic nephropathy consists of 10-15 parts of Angelica, 8-11 parts of Astragalus, 5-8 parts of Poria, 3-5 parts of Ginseng, and 3-6 parts of Codonopsis Codonopsis , 7-10 parts of Atractylodes macrocephala, 2-4 parts of corn silk, 6-10 parts of tangerine peel, 10-12 parts of Cimicifuga, 10-13 parts of Bupleurum, 8-10 parts of licorice, 15-20 parts of japonica rice, 12-12 parts of Anemarrhena 15 parts, 4-8 parts of Ophiopogon japonicus, 11-15 parts of kudzu root, 10-15 parts of Rehmannia glutinosa, 9-13 parts of Achyranthes bidentata, 10-15 parts of plantain, 6-10 parts of Chuanxiong, 8-10 parts of salvia miltiorrhiza and Immortal Grass consists of 7 to 10 parts.
本发明的另一目的在于提供一种治疗早期糖尿病肾病的当归黄芪治疗试剂的制备方法包括以下步骤:Another object of the present invention is to provide a preparation method of Angelica Astragali therapeutic reagent for the treatment of early diabetic nephropathy comprising the following steps:
步骤一:备药:将所述原料按配方重量配比好,将原料去除杂质、洗净,放置于阴凉干燥处自然风干;Step 1: Preparation of medicine: mix the raw materials according to the weight ratio of the formula, remove impurities from the raw materials, wash them, and place them in a cool and dry place to dry naturally;
步骤二:炒制:将药用炒制砂锅预热至80℃~85℃后,逐一放入原料中的每个组分,单独进行炒制,用文火炒制焦黄后冷却至室温,将各炒制组分进行搅拌混合,得到混合炒制组分;Step 2: Frying: Preheat the medicinal frying casserole to 80°C-85°C, put each component in the raw material one by one, fry separately, stir fry with a slow fire until it turns brown, then cool to room temperature, and put each The fried components are stirred and mixed to obtain the mixed fried components;
步骤三:粉碎:将混合炒制组分放入粉碎装置中进行粉碎,将粉碎后的组分过100-120目筛,经过3次过筛后,取筛下细料;Step 3: Pulverization: Put the mixed and fried components into a pulverization device for pulverization, pass the pulverized components through a 100-120 mesh sieve, and after 3 times of sieving, take the fine material under the sieve;
步骤四:灭菌:将过筛后的细料置于60Co-γ的辐射源中,辐射强度为15kGy,辐射剂量率为3.6kGy/h,进行电离辐射杀灭细菌;Step 4: Sterilization: Place the sieved fine material in a radiation source of 60Co-γ, the radiation intensity is 15kGy, and the radiation dose rate is 3.6kGy/h, and ionizing radiation is carried out to kill bacteria;
步骤五:分装:按一定重量分别将筛下灭菌后的细料分装至胶囊内,即得到所述试剂。Step 5: Subpackage: subpackage the sterilized fine material under sieve into capsules according to a certain weight to obtain the reagent.
进一步,所述粉碎采用低温粉碎。Further, the pulverization adopts low-temperature pulverization.
进一步,所述胶囊中细料的质量为0.25克。Further, the mass of the fine material in the capsule is 0.25 grams.
进一步,所述粉碎使用的电机的数学模型为:Further, the mathematical model of the motor used in the pulverization is:
Te=μJ(λdriqs-λqrids);T e =μJ(λ dr i qs -λ qr i ds );
其中,为极对数,d、q为静止坐标系,M、T坐标系上的电机数学模型为:in, is the number of pole pairs, d and q are the static coordinate system, and the mathematical model of the motor on the M and T coordinate system is:
其中,e表示同步速坐标系上的参数。Among them, e represents the parameters on the synchronous speed coordinate system.
进一步,所述电机的电压方程为:Further, the voltage equation of the motor is:
其中,Uua、Uva、Uwa为三相绕组相电压,Ra为每相绕组电阻;Iua、Iva、Iwa为三相绕组相电流,ψua、ψva、ψwa为三相电枢绕组磁链,p=d/dt为微分算子;Among them, U ua , U va , U wa are the phase voltages of the three-phase windings, R a is the resistance of each phase winding; I ua , I va , I wa are the phase currents of the three-phase windings, and ψ ua , ψ va , ψ wa are the three Phase armature winding flux linkage, p=d/dt is a differential operator;
所述电机的定子电压方程为:The stator voltage equation of the motor is:
运行电势eA、eB、eC为:The operating potentials e A , e B , and e C are:
ψfu、ψfv、ψfw为三相绕组转子每极永磁铁磁链,ψfa为用永磁铁磁通,L′a为电枢绕组的电感,M′a为电枢绕组间的互感。ψ fu , ψ fv , ψ fw are the permanent magnet flux linkages of each pole of the three-phase winding rotor, ψ fa is the permanent magnet flux, L′ a is the inductance of the armature winding, and M′ a is the mutual inductance between the armature windings.
综上所述,本发明的优点及积极效果为:In summary, the advantages and positive effects of the present invention are:
本发明中的当归、丹参、川芎能够补血活血,除烦安神,保护肾脏,减少肾单位的损伤,增加肾血流量,改善肌酐清除率,降低月尿素氮,对急性肾功能衰竭,有明显的保护肾脏的作用;黄芪、茯苓、人参、党参、白术、粳米、葛根、怀牛膝能补气健脾,保护肾脏,配合使用能降血糖,减少蛋白尿;玉米须、知母、车前草有利尿作用,并能减轻庆大霉素所致的肾毒性损害,能降低尿糖;神仙草、陈皮、升麻、甘草诸药可清热解毒、疏肝升阳有效防止肾衰竭的发生。Angelica sinensis, Salvia miltiorrhiza, and Rhizoma chuanxiong in the present invention can nourish blood and activate blood, relieve troubles and calm the nerves, protect the kidneys, reduce nephron damage, increase renal blood flow, improve creatinine clearance, reduce monthly urea nitrogen, and have obvious effects on acute renal failure. Kidney protection; Astragalus, Poria, Ginseng, Codonopsis Atractylodes, Atractylodes macrocephala, Japonica rice, Pueraria root, and Achyranthes bidentata can invigorate qi and invigorate the spleen, protect the kidneys, and can lower blood sugar and proteinuria when used together; corn silk, anemarrhena, plantain It has a diuretic effect, and can reduce the nephrotoxic damage caused by gentamicin, and can reduce urine sugar; the herbs of fairy grass, tangerine peel, cohosh, and licorice can clear away heat and detoxify, soothe the liver and raise yang, and effectively prevent the occurrence of kidney failure.
本发明能够补血活血,除烦安神,保护肾脏,减少肾单位的损伤,增加肾血流量,改善肌酐清除率,降低月尿素氮,对急性肾功能衰竭,保护肾脏;能降血糖,减少蛋白尿;并能减轻庆大霉素所致的肾毒性损害,能降低尿糖;神仙草、陈皮、升麻、甘草诸药可清热解毒、疏肝升阳有效防止肾衰竭的发生,对使用患者没有任何毒副作用。The present invention can replenish blood and activate blood, eliminate troubles and soothe the nerves, protect the kidney, reduce nephron damage, increase renal blood flow, improve creatinine clearance rate, reduce monthly urea nitrogen, and protect the kidney against acute renal failure; it can lower blood sugar and reduce proteinuria ; and can reduce the nephrotoxicity damage caused by gentamicin, and can reduce urine sugar; the medicines of fairy grass, tangerine peel, cohosh, and licorice can clear away heat and detoxify, soothe the liver and raise yang, effectively prevent the occurrence of renal failure, and have no effect on the use of patients any side effects.
制备过程中采用低温粉碎方法,变中药的韧性破碎为脆性破碎,以此来减小颗粒破碎前的形变量,保证足够的破碎空间和降低能耗。In the preparation process, a low-temperature crushing method is adopted to change the ductile crushing of the traditional Chinese medicine into brittle crushing, so as to reduce the deformation of the particles before crushing, ensure sufficient crushing space and reduce energy consumption.
附图说明Description of drawings
图1是本发明实施例提供的治疗早期糖尿病肾病的当归黄芪治疗试剂的制备流程图。Fig. 1 is a flow chart of the preparation of the Angelica Astragali therapeutic reagent for treating early diabetic nephropathy provided by the embodiment of the present invention.
具体实施方式Detailed ways
为能进一步了解本发明的发明内容、特点及功效,兹例举以下实施例,并配合附图详细说明如下。In order to further understand the content, features and effects of the present invention, the following examples are given, and detailed descriptions are given below with reference to the accompanying drawings.
下面结合附图对本发明的结构作详细的描述。The structure of the present invention will be described in detail below in conjunction with the accompanying drawings.
本发明实施例提供的治疗早期糖尿病肾病的当归黄芪治疗试剂按照质量份数由当归10~15份、黄芪8~11份、茯苓5~8份、人参3~5份、党参3~6份、白术7~10份、玉米须2~4份、陈皮6~10份、升麻10~12份、柴胡10~13份、甘草8~10份、粳米15~20份、知母12~15份、麦冬4~8份、葛根11~15份、熟地10~15份、怀牛膝9~13份、车前草10~15份、川芎6~10份、丹参8~10份和神仙草7~10份组成。The Angelica Astragalus treatment reagent for treating early diabetic nephropathy provided by the embodiments of the present invention consists of 10-15 parts of Angelica sinensis, 8-11 parts of Astragalus membranaceus, 5-8 parts of Poria cocos, 3-5 parts of ginseng, 3-6 parts of Codonopsis pilosula, 7-10 parts of Atractylodes macrocephala, 2-4 parts of corn silk, 6-10 parts of tangerine peel, 10-12 parts of Cimicifuga, 10-13 parts of Bupleurum, 8-10 parts of licorice, 15-20 parts of japonica rice, 12-15 parts of Anemarrhena 4-8 parts of Radix Ophiopogon japonicus, 11-15 parts of Pueraria Radix, 10-15 parts of Rehmannia glutinosa, 9-13 parts of Achyranthes bidentata, 10-15 parts of Plantain, 6-10 parts of Chuanxiong, 8-10 parts of Salvia miltiorrhiza and Shenxian Grass consists of 7-10 parts.
如图1所示,本发明实施例提供的用于防治痛风的中药复方试剂的制备方法包括以下步骤:As shown in Figure 1, the preparation method of the Chinese medicine compound reagent for the prevention and treatment of gout provided by the embodiment of the present invention comprises the following steps:
S101:备药:将所述原料按配方重量配比好,将原料去除杂质、洗净,放置于阴凉干燥处自然风干;S101: Prepare the medicine: mix the raw materials according to the weight ratio of the formula, remove impurities from the raw materials, wash them, and place them in a cool and dry place to dry naturally;
S102:炒制:将药用炒制砂锅预热至80℃~85℃后,逐一放入原料中的每个组分,单独进行炒制,用文火炒制焦黄后冷却至室温,将各炒制组分进行搅拌混合,得到混合炒制组分;S102: Frying: Preheat the medicinal frying casserole to 80°C-85°C, put each component in the raw material one by one, fry separately, stir fry with a slow fire until it turns brown, cool to room temperature, and fry each component The components are stirred and mixed to obtain the mixed and fried components;
S103:粉碎:将混合炒制组分放入粉碎装置中进行粉碎,将粉碎后的组分过100-120目筛,经过3次过筛后,取筛下细料;S103: Pulverization: put the mixed and fried components into a pulverization device for pulverization, pass the pulverized components through a 100-120 mesh sieve, and take the fine material under the sieve after 3 times of sieving;
S104:灭菌:将过筛后的细料置于60Co-γ的辐射源中,辐射强度为15kGy,辐射剂量率为3.6kGy/h,进行电离辐射杀灭细菌;S104: Sterilization: place the sieved fine material in a 60Co-γ radiation source with a radiation intensity of 15kGy and a radiation dose rate of 3.6kGy/h, and perform ionizing radiation to kill bacteria;
S105:分装:按一定重量分别将筛下灭菌后的细料分装至胶囊内,即得到所述试剂。S105: Subpackage: subpackage the sterilized fine material under sieve into capsules according to a certain weight, so as to obtain the reagent.
进一步,所述粉碎采用低温粉碎。Further, the pulverization adopts low-temperature pulverization.
进一步,所述胶囊中细料的质量为0.25克。Further, the mass of the fine material in the capsule is 0.25 grams.
进一步,所述粉碎使用的电机的数学模型为:Further, the mathematical model of the motor used in the pulverization is:
Te=μJ(λdriqs-λqrids);T e =μJ(λ dr i qs -λ qr i ds );
其中,为极对数,d、q为静止坐标系,M、T坐标系上的电机数学模型为:in, is the number of pole pairs, d and q are the static coordinate system, and the mathematical model of the motor on the M and T coordinate system is:
其中,e表示同步速坐标系上的参数。Among them, e represents the parameters on the synchronous speed coordinate system.
进一步,所述电机的电压方程为:Further, the voltage equation of the motor is:
其中,Uua、Uva、Uwa为三相绕组相电压,Ra为每相绕组电阻;Iua、Iva、Iwa为三相绕组相电流,ψua、ψva、ψwa为三相电枢绕组磁链,p=d/dt为微分算子;Among them, U ua , U va , U wa are the phase voltages of the three-phase windings, R a is the resistance of each phase winding; I ua , I va , I wa are the phase currents of the three-phase windings, and ψ ua , ψ va , ψ wa are the three Phase armature winding flux linkage, p=d/dt is a differential operator;
所述电机的定子电压方程为:The stator voltage equation of the motor is:
运行电势eA、eB、eC为:The operating potentials e A , e B , and e C are:
ψfu、ψfv、ψfw为三相绕组转子每极永磁铁磁链,ψfa为用永磁铁磁通,L′a为电枢绕组的电感,M′a为电枢绕组间的互感。ψ fu , ψ fv , ψ fw are the permanent magnet flux linkages of each pole of the three-phase winding rotor, ψ fa is the permanent magnet flux, L′ a is the inductance of the armature winding, and M′ a is the mutual inductance between the armature windings.
下面结合具体实施例对本发明的药理作用作进一步描述。The pharmacological action of the present invention will be further described below in conjunction with specific examples.
当归:其根可入药,具有补血活血,调经止痛,润燥滑肠、抗癌、抗老防老、免疫之功效。Angelica: Its root can be used as medicine, which has the effects of nourishing blood and promoting blood circulation, regulating menstruation and relieving pain, moistening dryness and smoothing intestines, anti-cancer, anti-aging and anti-aging, and immunity.
黄芪:本品为豆科植物蒙古黄芪的根,功能主治为:补气固表,托毒排脓,利尿,生肌;用于气虚乏力、久泻脱肛、自汗、水肿、子官脱垂、慢性肾炎蛋白尿、糖尿病、疮口久不愈合。Astragalus: This product is the root of the leguminous plant Astragalus mongolica. Its functions and indications are: tonifying qi and solidifying the surface, detoxifying and expelling pus, diuresis, and promoting muscle growth; used for qi deficiency and fatigue, chronic diarrhea and prolapse of the anus, spontaneous sweating, edema, and prolapse of the genitals , chronic nephritis proteinuria, diabetes, sores that do not heal for a long time.
茯苓:利水渗湿,健脾,宁心,用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。Poria cocos: inducing diuresis and expelling dampness, invigorating the spleen, calming the mind, used for edema, oliguria, dizziness and palpitation due to phlegm retention, deficiency of the spleen, lack of food, loose stool, restlessness, palpitation and insomnia.
人参:人参的肉质根为著名强壮滋补药,适用于调整血压、恢复心脏功能、神经衰弱及身体虚弱等症,也有祛痰、健胃、利尿、兴奋等功效。Ginseng: The fleshy root of ginseng is a famous strong tonic. It is suitable for adjusting blood pressure, restoring heart function, neurasthenia and physical weakness.
党参:具有补中益气,健脾益肺之功效,党参有增强免疫力、扩张血管、降压、改善微循环、增强造血功能等作用。Codonopsis: It has the effects of invigorating the middle and Qi, invigorating the spleen and lungs. Codonopsis has the functions of enhancing immunity, dilating blood vessels, lowering blood pressure, improving microcirculation, and enhancing hematopoietic function.
白术:白术具有健脾益气,燥湿利水,止汗,安胎的功效,用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗。Atractylodes: Atractylodes have the effects of strengthening the spleen and nourishing qi, dampness and water, antiperspiration, and tires. It is used for spleen deficiency and food, abdominal distension and diarrhea, sputum dizziness, edema, and self -sweating.
玉米须:禾本科植物玉蜀黍的花柱和柱头,有利尿消肿,清肝利胆的功效。Corn silk: the style and stigma of corn, a grass plant, has the effect of diuretic and swelling, clearing liver and gallbladder.
陈皮:为芸香科植物橘及其栽培变种的干燥成熟果皮用于脘腹胀满,食少吐泻,咳嗽痰多。Tangerine peel: it is the dry ripe fruit peel of Rutaceae plant Tangerine and its cultivars, which is used for distension and fullness in the abdomen, lack of appetite, vomiting and diarrhea, and cough with excessive phlegm.
升麻:毛莨科植物大三叶升麻、兴安升麻或升麻的干燥根茎。主要功效,发表透疹,清热解毒,升阳举陷。Cimicifuga: The dry rhizome of Cimicifuga clover, Xing'an Cimicifuga or Cimicifuga sativa of Ranunculaceae. The main effect is to release rash, clear away heat and detoxify, raise sun and lift depression.
柴胡:有和解表里,疏肝升阳之功效;用于感冒发热、寒热往来、疟疾、肝郁气滞、胸肋胀痛、脱肛、子宫脱垂、月经不调。Bupleurum: It has the effect of reconciling the exterior and interior, soothing the liver and promoting yang; it is used for cold and fever, alternating cold and heat, malaria, liver depression and stagnation of qi, sternal rib pain, anal prolapse, uterine prolapse, and irregular menstruation.
甘草:气微,味甜而特殊,功能主治清热解毒、祛痰止咳、脘腹等。Licorice root: Slight gas, sweet and special taste, functions mainly for clearing away heat and detoxification, eliminating phlegm and relieving cough, abdominal distension, etc.
粳米:具有养阴生津、除烦止渴、健脾胃、补中气、固肠止泻的功效。Japonica rice: It has the effects of nourishing yin and promoting body fluid, relieving restlessness and quenching thirst, invigorating the spleen and stomach, invigorating the middle Qi, strengthening the intestines and relieving diarrhea.
知母:功能主治,滋阴降火,润燥滑肠;治烦热消渴,骨蒸劳热,肺热咳嗽,大便燥结,小便不利。Anemarrhena: Functions and indications, nourishing yin and reducing fire, moistening dryness and smoothing intestines; treating dysphoria and thirst, bone steam and labor heat, cough due to lung heat, dry stool, dysuria.
麦冬:功能主治为,养阴生津,润肺止咳;用于肺胃阴虚之津少口渴、干咳咯血;心阴不足之心悸易惊及热病后期热伤津液等。Ophiopogon japonicus: Functions and indications: Nourish yin and promote body fluid, moisten the lungs and relieve cough; used for lack of fluid, thirst, dry cough and hemoptysis due to deficiency of yin in the lung and stomach;
葛根:常用于表证发热,项背强痛,麻疹不透,热病口渴,阴虚消渴,热泻热痢,脾虚泄泻。Radix Puerariae: Commonly used for superficial syndromes of fever, stiff neck and back pain, opaque measles, fever and thirst, yin deficiency and thirst, heat diarrhea and dysentery, and diarrhea due to spleen deficiency.
熟地:可用于血虚萎黄,眩晕,心悸失眠,月经不调,崩漏等症,亦可用于肾阴不足的潮热骨蒸、盗汗、遗精、消渴等症。Rehmannia glutinosa: It can be used for blood deficiency, chlorosis, dizziness, palpitations, insomnia, irregular menstruation, metrorrhagia, etc. It can also be used for hot flashes, night sweats, nocturnal emission, and thirst due to deficiency of kidney yin.
怀牛膝:其功能可以补肝益肾、强壮筋骨、通经络、散恶血,常用于治疗寒湿,腰膝骨疼、腰膝酸软,四肢拘挛、经血不调、产后瘀血腹疼、血淋、跌打损伤及屈膝碍等症。Huai Achyranthes bidentata: Its functions can nourish the liver and kidney, strengthen the muscles and bones, clear the meridians, and disperse evil blood. It is often used to treat cold and dampness, bone pain in the waist and knees, soreness in the waist and knees, spasms of the limbs, irregular menstrual blood, postpartum blood stasis, abdominal pain, Bleeding, bruises and knee flexion embolism.
车前草:为车前草科植物车前及平车前的全株,味甘,性寒。具有利尿、清热、明目、祛痰的功效,主治小便不通、淋浊、带下、尿血、黄疸、水肿、热痢、泄泻、鼻衄、目赤肿痛、喉痹、咳嗽、皮肤溃疡等。Plantain: the whole plant of Plantaineceae plant Plantain and Flat Plantain, sweet in taste and cold in nature. It has the effects of diuresis, clearing away heat, improving eyesight, and eliminating phlegm. It is mainly used to treat obstructed urination, stranguria, leukorrhea, hematuria, jaundice, edema, hot dysentery, diarrhea, epistaxis, red eyes and swelling, sore throat, cough, and skin ulcers. Wait.
川芎:常用于活血行气,祛风止痛,活血祛瘀作用广泛,适宜瘀血阻滞各种病症;祛风止痛,效用甚佳,可治头风头痛、风湿痹痛等症。Ligusticum Chuanxiong: It is often used to promote blood circulation, expel wind and relieve pain. It has a wide range of functions in promoting blood circulation and removing blood stasis.
丹参:具有活血祛瘀,通经止痛,清心除烦,凉血消痈之功效,用于胸痹心痛,脘腹胁痛,瘕瘕积聚,热痹疼痛,心烦不眠,月经不调,痛经经闭,疮疡肿痛之症。Salvia miltiorrhiza: It has the effects of promoting blood circulation and removing blood stasis, clearing the menstrual flow, relieving pain, clearing the heart and relieving restlessness, cooling blood and eliminating carbuncle. It is used for chest pain and heart pain, epigastric and hypochondriac pain, accumulation of lumps in the abdomen, heat arthralgia pain, upset and insomnia, irregular menstruation, dysmenorrhea closed, sores, swelling and pain.
神仙草:具有调节血压,降低血脂,调节血糖,促进尿酸排泄的功效。Immortal Grass: It has the effects of regulating blood pressure, lowering blood fat, regulating blood sugar, and promoting uric acid excretion.
本发明中的当归、丹参、川芎能够补血活血,除烦安神,保护肾脏,减少肾单位的损伤,增加肾血流量,改善肌酐清除率,降低月尿素氮,对急性肾功能衰竭,有明显的保护肾脏的作用;黄芪、茯苓、人参、党参、白术、粳米、葛根、怀牛膝能补气健脾,保护肾脏,配合使用能降血糖,减少蛋白尿;玉米须、知母、车前草有利尿作用,并能减轻庆大霉素所致的肾毒性损害,能降低尿糖;神仙草、陈皮、升麻、甘草诸药可清热解毒、疏肝升阳有效防止肾衰竭的发生。Angelica sinensis, Salvia miltiorrhiza, and Rhizoma chuanxiong in the present invention can nourish blood and activate blood, relieve troubles and calm the nerves, protect the kidneys, reduce nephron damage, increase renal blood flow, improve creatinine clearance, reduce monthly urea nitrogen, and have obvious effects on acute renal failure. Kidney protection; Astragalus, Poria, Ginseng, Codonopsis Atractylodes, Atractylodes macrocephala, Japonica rice, Pueraria root, and Achyranthes bidentata can invigorate qi and invigorate the spleen, protect the kidneys, and can lower blood sugar and proteinuria when used together; corn silk, anemarrhena, plantain It has a diuretic effect, and can reduce the nephrotoxic damage caused by gentamicin, and can reduce urine sugar; the herbs of fairy grass, tangerine peel, cohosh, and licorice can clear away heat and detoxify, soothe the liver and raise yang, and effectively prevent the occurrence of kidney failure.
实施例1:当归10份、黄芪11份、茯苓8份、人参3份、党参4份、白术8份、玉米须2份、陈皮6份、升麻10份、柴胡10份、甘草8份、粳米15份、知母12份、麦冬4份、葛根15份、熟地15份、怀牛膝9份、车前草15份、川芎10份、丹参10份、神仙草7份。Example 1: 10 parts of angelica, 11 parts of astragalus, 8 parts of Poria cocos, 3 parts of ginseng, 4 parts of codonopsis, 8 parts of Atractylodes macrocephala, 2 parts of corn silk, 6 parts of tangerine peel, 10 parts of cohosh, 10 parts of bupleurum, and 8 parts of licorice , 15 parts of japonica rice, 12 parts of Anemarrhena, 4 parts of Ophiopogon japonicus, 15 parts of kudzu root, 15 parts of Rehmannia glutinosa, 9 parts of Achyranthes bidentata, 15 parts of plantain, 10 parts of Chuanxiong, 10 parts of salvia miltiorrhiza, and 7 parts of fairy grass.
实施例2:当归15份、黄芪11份、茯苓8份、人参4份、党参6份、白术7份、玉米须4份、陈皮10份、升麻12份、柴胡13份、甘草10份、粳米18份、知母12份、麦冬8份、葛根15份、熟地15份、怀牛膝13份、车前草10份、川芎6份、丹参8份、神仙草8份。Example 2: 15 parts of angelica, 11 parts of astragalus, 8 parts of poria cocos, 4 parts of ginseng, 6 parts of codonopsis, 7 parts of Atractylodes macrocephala, 4 parts of corn silk, 10 parts of tangerine peel, 12 parts of cohosh, 13 parts of bupleurum, and 10 parts of licorice , 18 parts of japonica rice, 12 parts of Anemarrhena, 8 parts of Ophiopogon japonicus, 15 parts of kudzu root, 15 parts of Rehmannia glutinosa, 13 parts of Achyranthes bidentata, 10 parts of plantain, 6 parts of Chuanxiong, 8 parts of salvia miltiorrhiza, and 8 parts of fairy grass.
实施例3:当归12份、黄芪10份、茯苓6份、人参4份、党参4份、白术8份、玉米须3份、陈皮7份、升麻11份、柴胡12份、甘草9份、粳米16份、知母14份、麦冬6份、葛根13份、熟地12份、怀牛膝10份、车前草11份、川芎8份、丹参9份、神仙草9份。Example 3: 12 parts of angelica, 10 parts of astragalus, 6 parts of poria cocos, 4 parts of ginseng, 4 parts of codonopsis, 8 parts of Atractylodes macrocephala, 3 parts of corn silk, 7 parts of tangerine peel, 11 parts of cohosh, 12 parts of bupleurum, and 9 parts of licorice , 16 parts of japonica rice, 14 parts of Anemarrhena, 6 parts of Ophiopogon japonicus, 13 parts of kudzu root, 12 parts of Rehmannia glutinosa, 10 parts of Achyranthes bidentata, 11 parts of plantain, 8 parts of Chuanxiong, 9 parts of salvia miltiorrhiza, and 9 parts of fairy grass.
以上所述仅是对本发明的较佳实施例而已,并非对本发明作任何形式上的限制,凡是依据本发明的技术实质对以上实施例所做的任何简单修改,等同变化与修饰,均属于本发明技术方案的范围内。The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention in any form. Any simple modifications made to the above embodiments according to the technical essence of the present invention, equivalent changes and modifications, all belong to this invention. within the scope of the technical solution of the invention.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811035022.6A CN109091631A (en) | 2018-09-06 | 2018-09-06 | The Radix Angelicae Sinensis Astragalus in Treating reagent and preparation method for treating early diabetic nephropathy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811035022.6A CN109091631A (en) | 2018-09-06 | 2018-09-06 | The Radix Angelicae Sinensis Astragalus in Treating reagent and preparation method for treating early diabetic nephropathy |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109091631A true CN109091631A (en) | 2018-12-28 |
Family
ID=64865246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811035022.6A Pending CN109091631A (en) | 2018-09-06 | 2018-09-06 | The Radix Angelicae Sinensis Astragalus in Treating reagent and preparation method for treating early diabetic nephropathy |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109091631A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1824137A (en) * | 2005-12-20 | 2006-08-30 | 湖南省中医药研究院 | Sugar downbearing network vessel freeing Chinese medicinal preparation |
CN101036692A (en) * | 2007-04-10 | 2007-09-19 | 丽珠集团利民制药厂 | Application of radix codonopsis and radix astragali in the preparing of medicine for curing diabetes mellitus |
CN103623292A (en) * | 2013-12-24 | 2014-03-12 | 山东省中医药研究院 | Traditional Chinese medicine composition for treating diabetes mellitus |
CN108392583A (en) * | 2018-05-02 | 2018-08-14 | 宁夏医科大学 | A kind of Chinese medicine preparation for treating diabetic nephropathy |
-
2018
- 2018-09-06 CN CN201811035022.6A patent/CN109091631A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1824137A (en) * | 2005-12-20 | 2006-08-30 | 湖南省中医药研究院 | Sugar downbearing network vessel freeing Chinese medicinal preparation |
CN101036692A (en) * | 2007-04-10 | 2007-09-19 | 丽珠集团利民制药厂 | Application of radix codonopsis and radix astragali in the preparing of medicine for curing diabetes mellitus |
CN103623292A (en) * | 2013-12-24 | 2014-03-12 | 山东省中医药研究院 | Traditional Chinese medicine composition for treating diabetes mellitus |
CN108392583A (en) * | 2018-05-02 | 2018-08-14 | 宁夏医科大学 | A kind of Chinese medicine preparation for treating diabetic nephropathy |
Non-Patent Citations (2)
Title |
---|
周德生: "《中医偏方全书 珍藏本 豪华精装版》", 31 August 2018, 湖南科学技术出版社 * |
范军: "补中益气汤加味治疗糖尿病肾病100例", 《陕西中医》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103463404B (en) | Traditional Chinese medicine composition for treating liver and kidney yin deficiency | |
CN104667070A (en) | Medicine for treating skin diseases and preparation method of medicine | |
CN103736018A (en) | Medicine for treating gallstones and preparation method thereof | |
CN104383390A (en) | Chinese traditional medicine preparation for treating lung cancer | |
CN102274445A (en) | Cassia twig common burreed rhizome tumor eliminating pills | |
CN105106802A (en) | Traditional Chinese medicine composition for treating peripheral facial paralysis | |
CN109091631A (en) | The Radix Angelicae Sinensis Astragalus in Treating reagent and preparation method for treating early diabetic nephropathy | |
CN107596276A (en) | A kind of Chinese medicine composition promoting blood circulation and removing blood stasis, relaxing tendons and activating collaterals and preparation method thereof | |
CN109381627B (en) | Medicine for treating uremia and preparation method thereof | |
CN102091294B (en) | Traditional Chinese medicine composition for treating uremia | |
CN105126022A (en) | Medicine for treating ichthyosis and preparation method of medicine | |
CN105395884A (en) | Body-building medicinal wine | |
CN105213511A (en) | A kind of pharmaceutical composition is for the preparation of the purposes in treatment amenorrhea medicine | |
CN104547875A (en) | Traditional Chinese medicine for treating arteries and veins stasis type chest stuffiness and pain | |
CN104971340B (en) | A kind of Chinese medicine preparation and preparation method thereof for treating diarrhea associated with menstruation | |
CN103948856A (en) | Traditional Chinese medicament for treating artories and veims stasis syndrome chest stuffiness and pains | |
CN103784736A (en) | Medicine composition for treating pregnancy toxaemia of equus animals | |
CN103720973A (en) | Chinese herbal medicine for treating lumbar disc herniation and preparation method thereof | |
CN112439036B (en) | Application of traditional Chinese medicine composition in preparation of medicine for treating prostatic hyperplasia | |
CN107551183A (en) | It is a kind of dispel pathogenic wind and remove dampness, the Chinese medicine composition of swelling and pain relieving and preparation method thereof | |
CN100571739C (en) | Herbal mixture of treatment cardiovascular disease and preparation method thereof | |
CN105125860A (en) | Preparation for effectively treating osteoporosis | |
CN105267884A (en) | Medicine for mitral valve combined aortic lesion heart disease | |
CN105396034A (en) | Medicine for amebic dysentery | |
CN104998216A (en) | Traditional Chinese medicine tea bag for preventing and treating palpitation and preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181228 |
|
RJ01 | Rejection of invention patent application after publication |